MedTrace Logo

Cell-free DNA: a Non-invasive Test for Assessing Embryo Quality

NCT01397136 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2015-02-05

No results posted yet for this study

Summary

In the present project we propose to deeply characterize nuclear and/or mitochondrial DNA in embryo culture medium, in order to investigate whether both cell-free nucleic acid types may provide additional, reliable, predictive parameters for embryo viability and implantation potential.

Conditions

  • Culture Media
  • DNA

Sponsors & Collaborators

  • Merck Serono S.A., Geneva

    collaborator INDUSTRY

  • IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy

    lead OTHER

Principal Investigators

  • Paola Scaruffi, PhD · UOS Physiopathology of Human Reproduction, IRCCS AOU San Martino-IST, Genoa, Italy

Eligibility

Min Age
2 Days
Max Age
7 Days
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2014-07-31
Completion
2014-12-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01397136 on ClinicalTrials.gov